🆕 #EPICOVIDEHA publication in Blood Journal!

#Breakthrough #COVID19 in #vaccinated patients with #HematologicMalignancies

- Mortality rate 9%, lower than in the pre-vaccination

- MoABs, alone or combined with antivirals, show a better clinical outcome

ashpublications.org/blood/article-…

I'm having some serious FOMO about the #FASEBSRC #HematologicMalignancies meeting - If you are there, look out for my fellow Cancer Discovery Editor, Dr. Michele Hartsough! Also, check out our online Hematologic Malignancies collection: cancerdiscovery.aacrjournals.org/hema

Dr Erica Barnell from McDonnell Genome Institute describes examples of targeted gene panel to inform treatment decisions for AML patients Cancer Genomics Consortium (CGC) #CGCAnnual2020 #hematologicmalignancies

$BNGO 👀🔥🔥🔥 WHOAHH!! BIONANO TWEET: Dr. Saurabh Gupta Quest Diagnostics: “ #OGM is a gift to the #cytogenetics community and a breath of fresh air in this #NGS era. In the context of #HematologicMalignancies , #OGM provides comprehensiv... stocktwits.com/CiscoTrader/me…

De novo DNA methyltransferase DNMT3A is one of the most frequently mutated genes in adult myeloid and lymphoid malignancies. Venugopal et al provide a comprehensive review of alterations to DNMT3A in #HematologicMalignancies .
#ReviewArticle Olga Guryanova
bit.ly/325no5X

$BNGO 📣🔥BIONANO TWEET: Dr. Puiggros summarizes her findings: #OGM is valuable in assessing genomic complexity in #HematologicMalignancies , can detect majority of abnormalities when compared to standard methods, & can identif... stocktwits.com/CiscoTrader/me…

Today we announced FDA clearance of an IND application for GDA-201, our lead NAM-enabled cell therapy candidate for treatment of patients with follicular and diffuse large B-cell #lymphomas . More: bit.ly/36LL1WO #BloodCancer #HematologicMalignancies #GamidaNKCellTherapy

Interested to hear about the latest adventures of #DNMT3A and its mutations in #HematologicMalignancies , #ClonalHematopoiesis , and other conditions? Please check out our review in Cancer Research Cancer Research #cancer #epigenetics UF Health Cancer Center
bit.ly/325no5X

Are you ready for next month's exciting educational opportunities? Mark your calendars for December 10th, when Dr Jennelle C. Hodge will highlight Compendium of Cancer Genome Aberrations (CCGA) 🧬 as part of a workshop during ASH meeting on #hematologicmalignancies . Stay tuned! Cancer Genomics Consortium (CGC) #cancergenomics #CCGAwiki

#KnowAML will be interviewing #acutemyeloidleukemia experts during the 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) ( #SOHO2022 ), a 3.5-day event on #hematologicmalignancies . Watch the latest interviews at loom.ly/8gtEXeM #leukemia #leusm

$BNGO 📣🔥BIONANO TWEET: Summarizing his elegant data in #HematologicMalignancies , Dr Levy says #Bionano #Saphyr #OGM can eliminate need for multiple labor-intensive cytogenetic tests and maximize detection through standardized workflow. #Bionano Symposium2022 #Cytogenomics

Symptoms of your myeloproliferative neoplasm (MPN) won’t wait. Download the FINE Healthcare Communication Workbook for advice on how to discuss MPN symptoms with your Healthcare Professional. #MPNSM #FineIsNotEnough

Clark DuMontier NIH The Warren Alpert Medical School Michael A Liu Blood Journal Awesome!! More evidence for using objective measure for function in #hematologicmalignancies Young SIOG ASH SIOG #aml #geriheme

Hear the latest in #PrecisionMedicine as Steven Horwitz, Ahmet Dogan, Joseph D. Khoury, MD, FCAP and Naveen Pemmaraju, MD discuss CD30- and CD123-expressing #HematologicMalignancies bit.ly/30BiOf3

$CLRB Our colleagues Matt and Ben are at Great Debates & Updates Hematologic Malignancies @GreatDebatesHem. Stop by and say hello! #GDUHEM2022 #bloodcancer #mmsm #HematologicMalignancies #rarecancer #RareDisease

Call To Action📣Motivated Volunteers needed for the Compendium of Cancer Genome Aberrations pages Cancer Genomics Consortium (CGC). No experience needed! We learn together!👌I am working on B-ALL and we need you💯It is fun so please join us 🥳🤓 #CancerGenomics #teamwork #hematologicmalignancies

East coast friends! John P. Leonard, MD gave Adam Olszewski MD and I the challenge of debating the utility of CNS prophylaxis in DLBCL. Come learn and watch us duke it out on 04/13 in NYC! Register now: okt.to/7oIirY Great Debates & Updates #bloodcancer #HematologicMalignancies

Don't know where to go to catch the latest on #HematologicMalignancies ❓

The 🇨🇦 Canadian Connection Corner is the place for you! Join today: loom.ly/D-HTVn8

$CLRB Proud to be a sponsor of Great Debates and Updates Hematologic Malignancies (@GreatDebatesHem) taking place in #TimeSquare beginning today! #GDUHEM2022 #bloodcancer #HematologicMalignancies #WelcometoNewYork #mmsm

Kudos to Andrea Sitlinger David Bartlett, PhD for leading these initiatives for our patients Duke Hematologic Malignancies & Cellular Therapy - relevant now more than ever. Impact of #exercise on the immune system and outcomes in #hematologicmalignancies ashpublications.org/bloodadvances/…

We aim to develop better treatments that can make a real impact in people’s lives. Learn more about us here: bit.ly/3jNmovI

$MBXR #STSLungMets #Sarcoma #AcuteMyeloidLeukemia #Oncology

Setting treatment goals for yourself can feel daunting, especially when you’re living with a rare condition like immunoglobulin A (IgA) nephropathy. Here are 5 tips for achieving your treatment goals.

Honored to be accepted for a talk at one of my favorite conferences!@FASEBorg #hematologicmalignancies

Join us Feb. 11 for 2022 Care of Hematologic Malignancies Patient Update, Penn Medicine’s annual #CME #CNE . Hear the latest advances in #HematologicMalignancies research & care and what they mean for your patients. Penn Medicine MD Abramson Cancer Ctr. #bloodcancers med.upenn.edu/bloodcme2022/a…